An interventional study of AI-Supported Structured Fall Prevention Education in Parkinson Disease, Movement Disorders and Accidental Falls, sponsored by Halic University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Halic University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 172 studies in Parkinson Disease with a site in Turkey — 50 open to participants now, 56 under way, none of them phase 3. Parkinson Disease · Turkey.
Among the 172 studies in Parkinson Disease with a site in Turkey, this one is the 4th largest by planned enrollment of the 99 interventional ones that give a count, is one of 29 that started in 2026, is one of 92 with no phase, reaches primary completion later than 50 of the 55 other live ones, and was the 172nd registered.
4,578 studies on the registry are indexed under Parkinson Disease; 1,085 are open to participants now.
Browse Parkinson Disease studies →50 of the 172 studies in Parkinson Disease with a site in Turkey are open now. Recruiting first, the newest first:
Mustafa Kemal University · Sites in Turkey
Ages 35–75 · Healthy volunteers
Saglik Bilimleri Universitesi · Sites in Turkey
Ages 40+
Acibadem University · Sites in Turkey
Ages 40–85
Kahramanmaras Sutcu Imam University · Sites in Turkey
Ages 40–75
Medipol University · Sites in Turkey
Ages 50–80
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 748 Parkinson Disease studies recruiting now, 311 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
172 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 29 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 128 is above the median of 40 across 3,357 interventional studies indexed under Parkinson Disease.
Median enrollment 32 across the 99 interventional studies, 61 across the 73 observational. Of the 104 that completed or were terminated, 2 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 172 have an industry lead sponsor. The 10 most frequent:
Halic University is the lead sponsor of 86 studies on the registry; 15 are open to participants now.
Halic University has 1 study filed under Parkinson Disease — fewer than ten, so there is no comparison to draw.
18 of the studies in Parkinson Disease with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07678983Izmir Bakircay UniversityWhole-Body Vibration in Parkinson Disease | 2026-12 |
| NCT06154356Karamanoğlu Mehmetbey UniversityAction Observation and Motor Imagery Therapy in Parkinson's Disease | 2026-12 |
| NCT07730073Atlas UniversityEfficacy of LSVT-LOUD Therapy on Voice, Speech, and Quality of Life in Parkinson's Disease | 2026-12 |
| NCT07010783Ankara UniversityRespiratory Functions in Parkinson's Disease | 2026-12-01 |
| NCT07641556Saglik Bilimleri UniversitesiThe Effects of Tele-Rehabilitation-Based Dual-Task Upper Extremity Training in Patients With Parkinson's Disease | 2026-12-01 |
Add all 18 to your calendar (.ics) → With an account.
Among the 172 studies in Parkinson Disease with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Awake deep brain stimulation (DBS) is an effective surgical treatment for Parkinson's disease and other movement disorders, but patients remain at high risk of falls after surgery because of gait disturbance, postural instability, cognitive decline and transient postoperative delirium. Primary caregivers are the people in closest contact with these patients before surgery and after discharge, yet no caregiver-based fall prevention approach specific to this group has been tested. This single-center, parallel-group randomized controlled trial aims to evaluate the effect of an AI-supported structured fall prevention education given to primary caregivers before surgery on caregivers' fall prevention behaviors and on patients' postoperative falls and near-falls. Sixty-four patient-primary caregiver dyads will be randomized 1:1 to education plus usual care or usual care alone. Caregiver behaviors will be observed from postoperative day 0 to day 7 (or until discharge) using a structured observation form.
This is a single-center, two-arm, parallel-group randomized controlled trial with a 1:1 allocation ratio, conducted at the Neurosurgery Clinic of Basaksehir Cam and Sakura City Hospital, Istanbul, Turkiye. The unit of randomization is the patient-primary caregiver dyad; each patient and his/her primary caregiver are assigned to the same group, and only one primary caregiver is enrolled per patient.
Sample size was calculated with G*Power 3.1.9.7 based on a similar randomized controlled trial of caregiver fall prevention education (Wang, Zou \& Wang, 2022). Because the reported effect size was large (Cohen's d = 1.14), a more conservative d = 0.80 was used with two-sided alpha = 0.05, 80% power and 1:1 allocation, giving 26 dyads per group (52 in total). Allowing for 15% attrition (dropout, change of primary caregiver, missing observations), 32 dyads per group (64 dyads; 64 patients and 64 caregivers, 128 participants) will be enrolled.
Randomization: Dyads will be allocated by computer-generated block randomization (block size 4) by an independent researcher not involved in recruitment, education or data collection. Allocation concealment will be ensured with sequentially numbered, opaque, sealed envelopes prepared by the same independent researcher; the envelope is opened after written informed consent is obtained and the Patient and Primary Caregiver Descriptive Information Form is completed.
Intervention: In addition to routine clinical care, primary caregivers in the experimental group will receive AI-supported structured fall prevention education in the preoperative period. The content, prepared according to current fall prevention literature, covers safe support during first mobilization, bed-chair transfer, walking and toileting, control of environmental risks, and safe use of assistive walking devices. Education will be delivered face to face by the same researcher, with the same content and materials, in a room separate from patient rooms to minimize contamination between groups. The control group will receive routine clinical care only; for ethical reasons, the education content will be offered to control-group caregivers after data collection is completed.
Data collection: The Patient and Primary Caregiver Descriptive Information Form (26 items) will be completed by face-to-face interview before surgery. Caregivers' fall prevention behaviors will be assessed with the Caregiver Fall Prevention Behavior Observation Form (18 behaviors in 4 sections: first mobilization, bed-chair transfer, corridor walking, assistance with toileting and return; each scored 0-2; content validity assessed by 10 experts). First mobilization is observed on postoperative day 0, and the other three sections daily on postoperative days 1-7 (or until discharge if earlier). Falls and near-falls are recorded for each section and day. Observations are performed simultaneously and independently by two trained observers; if a fall risk arises during observation, observers intervene to ensure patient safety and the event is recorded as a near-fall.
Analysis: Data will be analyzed with IBM SPSS by an independent statistician blinded to group allocation, following the intention-to-treat principle, with 95% confidence intervals and p \< 0.05. Because the number of applicable behaviors differs between days, the daily mean behavior score (daily total divided by the number of observed behaviors; range 0-2) will be used, and its change over time will be analyzed with linear mixed-effects models (group, time and group-by-time interaction). Fall and near-fall counts will be analyzed with Poisson or, if needed, negative binomial regression. Inter-observer agreement will be assessed with weighted Cohen's kappa and intraclass correlation coefficient. Reporting will follow the CONSORT statement.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients:
Primary caregivers:
Exclusion Criteria:
Patients:
Primary caregivers:
Primary caregivers receive AI-supported structured fall prevention education, delivered face to face in the preoperative period, in addition to the clinic's routine care and information.
Behavioral: AI-Supported Structured Fall Prevention Education
Patient-caregiver dyads receive only the clinic's routine care and information. For ethical reasons, the education content will be offered to caregivers after data collection is completed.
Face-to-face structured education delivered by the same researcher to the primary caregiver before awake DBS surgery, using standardized AI-supported materials prepared according to current fall prevention literature. Content: safe support of the patient during first mobilization, bed-chair transfer, walking and toileting; control of environmental fall risks; and safe use of assistive walking devices. Education is given in a room separate from patient rooms.
Change in Mean Caregiver Fall Prevention Behavior Score
Measured with the Caregiver Fall Prevention Behavior Observation Form developed by the researchers (18 behaviors in 4 sections: first mobilization \[5\], bed-chair transfer \[4\], corridor walking \[5\], assistance with toileting and return \[4\]). Each behavior is scored 0 = not performed/performed incorrectly, 1 = partially correct, 2 = fully correct; behaviors not observed or not required on a given day are coded as not observed and excluded. Because the number of applicable behaviors differs between days, the daily mean behavior score (daily total score divided by the number of observed behaviors; range 0-2) is used to assess change over time; higher scores indicate more accurate and complete fall prevention behaviors. Observations are made independently by two trained observers.
Time frame: Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
Number of Patient Falls During Postoperative Hospitalization
Number and rate of patient falls observed during the postoperative hospital stay, recorded as yes/no for each observed activity and day on the Caregiver Fall Prevention Behavior Observation Form.
Time frame: Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
Number of Near-Fall Events During Postoperative Hospitalization
Number and rate of near-fall events (situations in which a fall risk arose and the observers intervened to ensure patient safety) during the postoperative hospital stay.
Time frame: Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
Plan to share: No — Individual participant data will not be shared in order to protect participant confidentiality.
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Mar 2027, 4 months later.
Of 1,295 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 4 months is below that.
Counting every sponsor, half of 1,371 studies reached it within 25 months; a quarter within 11 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Halic University